Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence – a meeting report

Laurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, Marco Cavaleri, Miles P. Davenport, Bradford D. Gessner, Brenda Gomes, Kyla Hayford, Alane Izu, Hector S. Izurieta, Victoria A. Jenkins, Randee Kastner, Phil Krause, Joshua Nealon, Lidia Oostvogels, Arto A. Palmu, Robert C. Read, Carla Saenz, Dean K. Smith, Suely Tuboi, Frank Vandendriessche, Marc Baay, Danielle Craig, Pieter Neels, Kaatje Bollaert
Biologicals · Elsevier · DOI: 10.1016/j.biologicals.2026.101886

Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.

Читать у издателя →

Похожие статьи